Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience

Patrizia Alvisi1 Pediatric Gastroenterology Unit, Pediatric Department, Maggiore Hospital, Bologna, Italy, [email protected]Correspondence[email protected]

Serena Arrigo2 Pediatric Gastroenterology and Endoscopy Unit, G Gaslini Children’s Hospital, Genoa, Italy

Salvatore Cucchiara3 Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy

Paolo Lionetti4 Gastroenterology and Nutrition Unit, Meyer Children’s Hospital, Florence, Italy

Erasmo Miele5 Pediatric Department, Federico II University of Naples, Naples, Italy

Claudio Romano6 Pediatric Gastroenterology, University of Messina, Messina, Italy

Alberto Ravelli7 Gastroenterology and GI Endoscopy Unit, University Department of Pediatrics, Children’s Hospital, Brescia, Italy

Daniela Knafelz8 Hepatology and Gastroenterology Unit, Bambino Gesù Hospital, Rome, Italy

Stefano Martelossi9 Department of Pediatrics, Institute of Child Health, IRCSS Burlo Garofolo, Trieste, Italy

Graziella Guariso10 University of Padua, Padua, Italy

Salvatore Accomando11 Pediatric Department, University of Palermo, G di Cristina Children’s Hospital, Palermo, Italy

Giovanna Zuin12 Pediatric Unit, Buzzi Hospital, Milan, Italy

Costantino De Giacomo13 Pediatric Unit, Niguarda Hospital, Milan, Italy

Lucio Balzani14 Morgagni Hospital, Forlì, Italy

Monia Gennari15 Emergency Pediatric Department, S Orsola Hospital, Bologna, Italy

Marina Aloi3 Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy

Your download is now in progress and you may close this window